DOSING STRATEGY TO MITIGATE CYTOKINE RELEASE SYNDROME FOR CD3 / C20 BISPECIFIC ANTIBODIES

MA53495AUndetermined Publication Date: 2021-12-08REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA53495
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-06-13
Filing Date
2019-08-30
Publication Date
2021-12-08
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.